34 Results
Sort By:
Published on November 28, 2017
University of British Columbia (UBC) and BC Children's Hospital Research Institute investigators have published new findings indicating that the degree to which close and comforting contact takes place between infants and their caregivers can affect children at the molecular level and that it remains detectable four years later. The study, “Epigenetic Correlates…
Published on June 20, 2017
Agena Bioscience said today that its MassARRAY® System has been chosen by Assurex Health for laboratory setup and sample processing of its GeneSight Psychotropic test, under an expanded partnership whose value was not disclosed. GeneSight Psychotropic is a laboratory-developed test designed to help clinicians analyze how a patient's genetic make-up…
Published on May 10, 2017
Scott Gottlieb, M.D., was confirmed as the new commissioner of the FDA late Tuesday, by U.S. Senate by a vote of 57 to 42. He also served as deputy FDA commissioner under President George W. Bush. Trump appointee Dr. Gottlieb, is a resident fellow at conservative think tank the American…
Published on May 1, 2015
Placebo responders are different from placebo nonresponders, with implications for the design of clinical trials and the provision of clinical care. Placebo responders, for example, are thought to have brain signaling pathways that differ in subtle ways from nonresponders’ pathways. Ultimately, these pathways—especially the dopamine, opioid, endocannabinoid, and serotonin pathways—differ…